Global Blood Brain Barrier Market is segmented By Type of Molecule (Small Molecules, Biologics), By Route of Administration (Oral, Intravenous, Intranasal, Others), By Disease Indication (Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Mucopolysaccharidosis Type II (Hunter Syndrome), Leptomeningeal Carcinomatosis, Mucopolysaccharidosis Type III A (Sanfilippo Syndrome A), By Therapeutic Area (Neurodegenerative Disorders, Lysosomal Storage Disorders, Neuro-Oncology Disorders), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned segments.